SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-013641
Filing Date
2020-02-10
Accepted
2020-02-10 16:45:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm207250-1_sc13ga.htm SC 13G/A 53709
  Complete submission text file 0001104659-20-013641.txt   55309
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82540 | Film No.: 20592532
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 18/F DES VOEUX ROAD WEST HONG KONG K3 999077
Business Address 18/F DES VOEUX ROAD WEST HONG KONG K3 999077 (852) 6106 0338
China In Shine Investment Ltd (Filed by) CIK: 0001743492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G/A